• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散加权磁共振成像在评估局部晚期宫颈癌新辅助化疗反应中的价值。

The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy.

机构信息

Department of Gynecology and Obstetrics, Second Xiangya Hospital, Central South University, Changsha, People's Republic of China.

出版信息

Int J Gynecol Cancer. 2012 Jul;22(6):1037-43. doi: 10.1097/IGC.0b013e31825736d7.

DOI:10.1097/IGC.0b013e31825736d7
PMID:22683941
Abstract

OBJECTIVE

The objective of this study was to investigate whether magnetic resonance diffusion-weighted imaging (DWI) of locally advanced cervical cancer (LACC) both in the sagittal and axial planes could be used to assess the response of LACC to neoadjuvant chemotherapy (NACT).

METHODS

Thirty women with LACC received conventional magnetic resonance imaging and DWI at 3 different times (before NACT, 2 weeks after the first NACT, and 2 weeks after the second NACT). Treatment response was determined according to the change in tumor size 2 weeks after the second NACT, and they were classified as the effective group and the ineffective group. The apparent diffusion coefficients (ADCs) were compared between 2 imaging planes, and dynamic changes in ADCs were observed in different chemotherapy-sensitive groups and imaging planes. One-way analysis of variance was calculated between those ADC parameters and tumor response.

RESULTS

The effective chemotherapy rate was 76.67%. Apparent diffusion coefficient values of the axial plane at 3 different times were 0.88 (SD, 0.08) × 10⁻³ mm²/s, 0.96 (SD, 0.10) × 10⁻³ mm²/s, and 1.19 (SD, 0.11) × 10⁻³ mm²/s, respectively. Meanwhile, ADC values of the sagittal planes were 0.89 (SD, 0.09) × 10⁻³ mm²/s, 0.97 (SD, 0.12) × 10⁻³ mm²/s, and 1.19 (SD, 0.12) × 10⁻³ mm²/s at 3 different stages. There were no statistical differences between the ADC values of the 2 planes at 3 different times (P = 0.927, P = 0.863, P = 0.946). Apparent diffusion coefficients 2 weeks after the first NACT were significantly increased compared with those before chemotherapy both in the axial and sagittal planes (P = 0.003, P = 0.012). In the ineffective group, ADCs 2 weeks after the first NACT were not statistically higher than those before chemotherapy (axial planes, P = 0.694; sagittal planes, P = 0.900). After 2 weeks of the first NACT, ADCs in both planes were obviously increased in the effective group than those in the ineffective group (P = 0.043, P = 0.022).

CONCLUSIONS

The axial and sagittal DWI may detect the changes in LACC after therapy. Apparent diffusion coefficient values measured both in the 2 planes may be used to evaluate the response of LACC to NACT.

摘要

目的

本研究旨在探讨局部晚期宫颈癌(LACC)在矢状面和轴位磁共振弥散加权成像(DWI)是否可用于评估 LACC 对新辅助化疗(NACT)的反应。

方法

30 例 LACC 患者分别于 NACT 前、NACT 后 2 周及 NACT 后 2 周接受常规磁共振成像和 DWI 检查。根据 NACT 后 2 周肿瘤大小的变化判断治疗反应,分为有效组和无效组。比较 2 个成像平面的表观扩散系数(ADC),观察不同化疗敏感组和成像平面的 ADC 变化。采用单因素方差分析比较这些 ADC 参数与肿瘤反应之间的关系。

结果

有效化疗率为 76.67%。3 个时间点轴位 DWI 的 ADC 值分别为 0.88(SD,0.08)×10⁻³mm²/s、0.96(SD,0.10)×10⁻³mm²/s 和 1.19(SD,0.11)×10⁻³mm²/s,而矢状位的 ADC 值分别为 0.89(SD,0.09)×10⁻³mm²/s、0.97(SD,0.12)×10⁻³mm²/s 和 1.19(SD,0.12)×10⁻³mm²/s。3 个时间点 2 个平面的 ADC 值差异均无统计学意义(P=0.927、P=0.863、P=0.946)。NACT 后 2 周,与化疗前相比,2 个平面的 ADC 值均显著升高(P=0.003、P=0.012)。在无效组中,NACT 后 2 周 ADC 值与化疗前相比无统计学差异(轴位,P=0.694;矢状位,P=0.900)。在有效组中,NACT 后 2 周,2 个平面的 ADC 值均明显高于无效组(P=0.043、P=0.022)。

结论

轴位和矢状位 DWI 可检测 LACC 治疗后的变化。2 个平面测量的 ADC 值可用于评估 LACC 对 NACT 的反应。

相似文献

1
The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy.弥散加权磁共振成像在评估局部晚期宫颈癌新辅助化疗反应中的价值。
Int J Gynecol Cancer. 2012 Jul;22(6):1037-43. doi: 10.1097/IGC.0b013e31825736d7.
2
Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.新辅助化疗引起的局部晚期宫颈癌磁共振扩散加权成像与病理微观结构的同步变化
J Magn Reson Imaging. 2015 Aug;42(2):427-35. doi: 10.1002/jmri.24779. Epub 2014 Oct 20.
3
Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.局部晚期宫颈癌新辅助化疗疗效的 T1 灌注磁共振成像基础评估。
Int J Gynecol Cancer. 2013 Sep;23(7):1270-8. doi: 10.1097/IGC.0b013e31829db950.
4
Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.使用体素内不相干运动扩散加权磁共振成像评估晚期宫颈癌对新辅助化疗的早期反应:一项初步研究。
Chin Med J (Engl). 2016 Mar 20;129(6):665-71. doi: 10.4103/0366-6999.177995.
5
Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.联合动态对比增强磁共振成像和扩散加权成像评估新辅助化疗对宫颈癌的疗效。
Tumori. 2020 Apr;106(2):155-164. doi: 10.1177/0300891619886656. Epub 2019 Nov 18.
6
Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.弥散加权磁共振成像在局部进展期乳腺癌新辅助化疗患者治疗前预测和疗效监测中的应用。
Acta Oncol. 2010 Apr;49(3):354-60. doi: 10.3109/02841861003610184.
7
Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.联合动态对比增强磁共振成像和弥散加权成像预测 FIGO 分期 IB2-IIA2 宫颈癌新辅助化疗效果。
Radiol Med. 2020 Dec;125(12):1233-1242. doi: 10.1007/s11547-020-01214-x. Epub 2020 May 18.
8
Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.弥散加权 MRI 在预测乳腺癌患者新辅助化疗反应中的应用。
Eur Radiol. 2013 Sep;23(9):2420-31. doi: 10.1007/s00330-013-2850-x. Epub 2013 May 8.
9
[Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].[磁共振扩散加权成像在子宫颈癌诊断及预后预测中的价值]
Zhonghua Zhong Liu Za Zhi. 2014 Feb;36(2):115-9.
10
Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.基于全肿瘤容积的体素内不相干运动定量参数评估局部进展期直肠癌新辅助化疗的病理完全缓解。
J Magn Reson Imaging. 2018 Jul;48(1):248-258. doi: 10.1002/jmri.25931. Epub 2017 Dec 27.

引用本文的文献

1
Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer.循环中的miR-326可作为局部晚期宫颈癌新辅助化疗反应的预测生物标志物。
Front Oncol. 2022 Nov 9;12:1036710. doi: 10.3389/fonc.2022.1036710. eCollection 2022.
2
Diffusion-weighted MRI to detect early response to chemoradiation in cervical cancer: A systematic review and meta-analysis.扩散加权磁共振成像检测宫颈癌放化疗早期反应:一项系统评价和荟萃分析。
Gynecol Oncol Rep. 2021 Oct 18;38:100883. doi: 10.1016/j.gore.2021.100883. eCollection 2021 Nov.
3
Imaging in Carcinoma Cervix and Revised 2018 FIGO Staging System: Implications in Radiology Reporting.
子宫颈癌的影像学检查与2018年修订的FIGO分期系统:对放射学报告的影响
Indian J Radiol Imaging. 2021 Sep 7;31(3):623-634. doi: 10.1055/s-0041-1735502. eCollection 2021 Jul.
4
Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.采用 MRI 对宫颈癌进行分期、复发和随访:FIGO 分期 2018 修订后欧洲泌尿生殖放射学会的更新指南。
Eur Radiol. 2021 Oct;31(10):7802-7816. doi: 10.1007/s00330-020-07632-9. Epub 2021 Apr 14.
5
Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.基于影像组学的局部晚期宫颈癌新辅助化疗疗效预测的多中心研究
EBioMedicine. 2019 Aug;46:160-169. doi: 10.1016/j.ebiom.2019.07.049. Epub 2019 Aug 6.
6
Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers.MRI在子宫内膜癌和宫颈癌分期及随访中的作用:陷阱与类似表现
Insights Imaging. 2019 Feb 13;10(1):19. doi: 10.1186/s13244-019-0696-8.
7
The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.PRICE 研究:放化疗后行根治性手术的局部晚期宫颈癌患者中常规磁共振成像和弥散加权磁共振成像的作用。
Eur Radiol. 2018 Jun;28(6):2425-2435. doi: 10.1007/s00330-017-5233-x. Epub 2018 Jan 9.
8
Role of Functional Magnetic Resonance Imaging Derived Parameters as Imaging Biomarkers and Correlation with Clinicopathological Features in Carcinoma of Uterine Cervix.功能磁共振成像衍生参数作为宫颈癌成像生物标志物的作用及其与临床病理特征的相关性
J Clin Diagn Res. 2017 Aug;11(8):XC06-XC11. doi: 10.7860/JCDR/2017/29165.10426. Epub 2017 Aug 1.
9
The value of advanced MRI techniques in the assessment of cervical cancer: a review.先进的磁共振成像技术在宫颈癌评估中的价值:综述
Insights Imaging. 2017 Oct;8(5):471-481. doi: 10.1007/s13244-017-0567-0. Epub 2017 Aug 21.
10
Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.使用体素内不相干运动扩散加权磁共振成像评估晚期宫颈癌对新辅助化疗的早期反应:一项初步研究。
Chin Med J (Engl). 2016 Mar 20;129(6):665-71. doi: 10.4103/0366-6999.177995.